查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1692146

宠物驱虫剂：市场占有率分析、产业趋势与统计、成长预测（2025-2030 年）

Pet Insect Repellants - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预测期内，宠物驱虫剂市场预计复合年增长率为 4.4%。

宠物驱虫剂-市场-IMG1

从长远来看，贫血、跛足、蜱麻痹以及蜱和跳蚤引起的搔痒等疾病的威胁日益严重，预计将在预测期内主要增加宠物驱虫产品的需求。

跳蚤和蜱虫是危害宠物最常见的害虫。这些占了 2021 年大部分份额，合计 63.8%。这意味着驱除跳蚤和蜱虫的剂型占了大部分市场份额，预计未来几年这一趋势将进一步成长。

各已开发国家和新兴国家宠物饲主数量的增加、媒介传播疾病的增加以及已开发国家宠物健康支出的增加是推动市场成长的因素，而严格的法规和化学品的毒性阻碍了市场的成长。

北美占据市场主导地位。随着北美地区宠物人性化的不断提升，宠物驱虫剂的需求也日益增加。人均动物保健支出的成长使宠物驱虫剂产业受益匪浅。例如，根据美国宠物产品协会 (APPA) 的数据，美国狗饲主在过去 12 个月中平均为每隻狗花费 1,880 美元，包括宠物食品、零食、玩具、维生素、美容、兽医检查以及遛狗/狗舍服务。宠物饲主对宠物健康重要性的认识不断提高，预计将在未来几年推动市场成长。

宠物驱虫剂的市场趋势

对宠物健康的关注和支出增加

人均动物保健支出的成长使宠物驱虫剂产业受益匪浅。例如，根据美国宠物产品协会 (APPA) 的数据，美国狗饲主在过去 12 个月中平均为每隻狗花费 1,880 美元，包括宠物食品、零食、玩具、维生素、美容、兽医检查以及遛狗/狗舍服务。同一时期，猫饲主平均每隻猫花费 902美国。兽医费是饲养宠物的最大开支。

此外，在过去十年中，美国人在宠物上的支出增加了一倍以上。例如，2010年，用于宠物的总支出约为455.3亿美元。在接下来的十年里，这项支出飙升至每年1,036亿美元。最大的年度增幅是从2017年到2018年，支出从695.1亿美元跃升至905亿美元，成长了30%。

同样，根据安大略省兽医协会 (OVMA) 的数据，在加拿大，照顾一隻小狗的平均每年费用为 3,242 加币。据美国疾病管制与预防中心称，2004年至2016年间，仅在美国就发现了七种透过受感染蜱虫叮咬传播的新型细菌菌株。这些病原体可以感染人类和狗，可能导致通用感染疾病。伴同性动物中各种疾病的发病率不断上升，导致全国范围内对诊断成像程序和预防疾病的补充剂的需求日益增长。

北美引领市场

北美是宠物驱虫剂的主要市场，2021 年约占总市场份额的 43.5% 。美国的宠物数量在全球整体排名第一。根据 2021-2022 年 APPA 全国宠物主人调查，70% 的美国家庭拥有某种宠物，高于 2019-2020 年调查中的 67%。事实上，14% 的受访者在疫情期间养了新宠物。此外，该国的宠物支出在过去一年中有所增加，35％的宠物主人增加了在宠物和宠物食品、保健产品和其他宠物护理用品（包括驱虫剂）上的支出，这预计将推动该国市场的发展。

例如，美国已发生一系列昆虫攻击宠物的事件，包括2020年亚利桑那州一群蜜蜂袭击并杀死三隻狗的事件，因此用于保护宠物和确保其健康的驱虫剂的需求预计将增加。

此外，加拿大市场上还有许多声称可以防止昆虫叮咬的产品。只有获得政府核准的安全和有效的药物才允许在该国使用。在加拿大，西尼罗河病毒和莱姆病是宠物健康的主要问题。药用驱虫剂在加拿大随处可见。例如，总部位于亚伯达省卡加利的製造商 Xerion Dispensary 生产的同类疗法配方 Mozi-Q 已将加拿大製造的驱虫剂推向市场，为日常宠物疾病提供安全、自然的解决方案。因此，预计预测期内宠物拥有量的增加和宠物中昆虫传播疾病的流行将推动宠物驱虫剂的需求。

宠物驱虫剂产业概况

全球宠物驱虫剂市场高度分散，参与者众多。 Zoetis Inc.、Elanco Animal Health、Hartz Mountain Corporation、Boehringer Ingelheim、PetIQ LLC、Central Garden &Pet Company、Merck and Co. Inc. 和 Viebac Group 是市场的主要企业。这些市场主要企业正在扩大业务，透过增加产品系列和收购市场上的其他地区或全球参与者来维持其市场地位。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第 1 章 简介

  • 研究假设和市场定义
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 市场概况
  • 市场驱动因素
  • 市场限制
  • 波特五力分析
    • 新进入者的威胁
    • 购买者和消费者的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争对手之间的竞争强度

第五章 市场区隔

  • 宠物类型
    • 狗
    • 猫
    • 鸟类
    • 其他动物
  • 错误类型
    • 打钩
    • 苍蝇
    • 蜜蜂
    • 跳蚤
    • 其他昆虫
  • 最终用户/应用程式
    • 宠物诊所
    • 宠物店
    • 其他最终用户/应用程式
  • 地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
      • 北美其他地区
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 其他亚太地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区
    • 中东和非洲
      • 南非
      • 其他中东和非洲地区

第六章 竞争格局

  • 最受欢迎的策略
  • 市场占有率分析
  • 公司简介
    • Merck And Co. Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH
    • Vibrac
    • The Hartz Mountain Corporation
    • Tianjin Ringpu Bio-technology
    • Zoetis Inc.
    • Central Garden & Pet

第七章 市场机会与未来趋势

第 8 章：COVID-19 对市场的影响

简介目录
Product Code: 90852

The Pet Insect Repellants Market is expected to register a CAGR of 4.4% during the forecast period.

Pet Insect Repellants - Market - IMG1

In the long run, the rising threat of diseases such as anemia, lame disease, tick paralysis, and itching caused by ticks and fleas majorly is anticipated to increase the demand for pet insect repellent products during the forecast period.

Among all the insects, fleas and ticks are the major types of insects that cause damage to the pet. These account for the majority share of 63.8% together in 2021. This states that the repellents of fleas and ticks contribute to most of the share, and this is further anticipated to drive during the coming years.

An increase in the number of pet owners in various developed and developing countries, an increase in vector-borne diseases, and an increase in pet health expenditure in the developed countries are the factors that drive the market growth, while stringent regulations and toxicity in the chemicals hamper the growth of the market.

North America dominates the market. The increasing demand for the pet repellents market can be attributed to the enhanced pet humanization in North America. The pet insect repellents market is benefiting tremendously, owing to the increasing per capita animal healthcare expenditure. For instance, according to the American Pet Product Association (APPA), Dog owners in the United States spent an average of USD 1,880 per canine in the prior 12 months, which includes pet food, treats, toys, vitamins, grooming, visits to the vet, and dog-walking/kennel services. The rising awareness among pet owners about the importance of pet health, and this, in turn, will drive market growth in the coming years.

Pet Insect Repellants Market Trends

Increased Focus and Expenditure on Pet Health

The pet insect repellents market is benefiting tremendously, owing to the increasing per capita animal healthcare expenditure. For instance, according to the American Pet Product Association (APPA), Dog owners in the United States spent an average of USD 1,880 per canine in the prior 12 months, which includes pet food, treats, toys, vitamins, grooming, visits to the vet, and dog-walking/kennel services. Cat owners, during the same time frame, spent an average of US 902 per feline. Among all, Vet bills are typically the costliest segment of the budget to own a pet, and lack of access can be prohibitive to pet ownership for many people.

Furthermore, in the past ten years, American pet spending has more than doubled. For instance, in 2010, the total money spent on pets was roughly USD 45.53 billion. Within the next decade, this spending has mushroomed to USD 103.6 billion annually. The biggest annual increase was between 2017 and 2018, when spending quickly jumped from USD 69.51 billion to USD 90.5 billion, a growth of 30%.

Similarly, in Canada, according to Ontario Veterinary Medical Association (OVMA), the annual cost of caring for a puppy was CAD 3,242. According to the Centers for Disease Control and Prevention, during the 13 years, from 2004 to 2016, seven new germs spreading through the bite of an infected tick were discovered in the United States alone. These germs can also infect people, alongside dogs, and cause zoonotic diseases. As the prevalence of various diseases in companion animals is increasing, the demand for diagnostic imaging procedures and supplements to prevent diseases is rising across the country.

North America Leads the Market

North America is the major market for pet insect repellants occupying about 43.5% share of the total market in 2021. The United States stands first in the overall pet population globally. According to the 2021-2022 APPA National Pet Owners Survey, 70% of US households own some pet, an increase from 67% in the 2019-2020 survey. In fact, 14% of total respondents obtained a new pet during the pandemic. Moreover, pet spending increased during the past year in the country, with 35% of pet owners spending more on their pet/pet supplies, including food, wellness-related products, and other pet care items, including insect repellants which are anticipated to drive the market in the country.

The insect attack incidences on pets in the country, for instance, in 2020, an aggressive swarm of bees fatally attacked three dogs in Arizona, will lead to an increase in demand for insect repellants to protect and ensure the well-being of the pets.

Further, in Canada, many products on the market claim to protect against insect bites. Only those that have been government-approved for their safety and effectiveness are allowed for use in the country. In Canada, the West Nile virus and Lyme disease are health concerns for pets. Medically formulated insect repellents are widespread in the country. For instance, Mozi-Q, a homeopathic formulation made by Xerion Dispensary, a manufacturing company based in Calgary, Alberta, has brought insect repellent made in Canada to the market that provides safe and natural solutions to everyday concerns in pets. Thus, increasing pet ownership and the spread of insect-transmitted diseases among pets are anticipated to drive the demand for pet insect repellants in t during the forecast period.

Pet Insect Repellants Industry Overview

The global pet insect repellent market is highly fragmented with alarge number of players. Zoetis Inc., Elanco Animal Health, the Hartz Mountain Corporation, Boehringer Ingelheim, PetIQ LLC, Central Garden & Pet Company, Merck and Co. Inc., and the Viebac Group are the key players in the market. These major players in the market are increasing their product portfolio and expanding their business to maintain their position in the market by acquiring the other regional or global players in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Pet Type
    • 5.1.1 Dogs
    • 5.1.2 Cats
    • 5.1.3 Birds
    • 5.1.4 Other Animals
  • 5.2 Insect Type
    • 5.2.1 Ticks
    • 5.2.2 Flies
    • 5.2.3 Bees
    • 5.2.4 Fleas
    • 5.2.5 Other Insect Type
  • 5.3 End User/Application
    • 5.3.1 Pet Clinic
    • 5.3.2 Pet Shops
    • 5.3.3 Other End Users/Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
      • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Russia
      • 5.4.2.7 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 Rest of Asia-Pacific
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle-East and Africa
      • 5.4.5.1 South Africa
      • 5.4.5.2 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Most Adopted Strategies
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles
    • 6.3.1 Merck And Co. Inc.
    • 6.3.2 Elanco Animal Health Incorporated
    • 6.3.3 Boehringer Ingelheim International GmbH
    • 6.3.4 Vibrac
    • 6.3.5 The Hartz Mountain Corporation
    • 6.3.6 Tianjin Ringpu Bio-technology
    • 6.3.7 Zoetis Inc.
    • 6.3.8 Central Garden & Pet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET